June 23, 2020   | Posted in: Announcements

Important notice regarding Sublocade

Sublocade is an extended-release formulation of buprenorphine for the management of opioid use disorder that was made available in British Columbia on April 30, 2020, through Pharmacare Special Authority. As this is a new drug in BC, Health Canada requires all prescribers to complete the manufacturer's course prior to prescribing. 

For more information, see the British Columbia Centre on Substance Use bulletin Sublocade (Extended-Release Buprenorphine) Information.